GlassScriptPhysician profile
Yin Liu
NPI 1235572934
$10,828.47
in general payments reported to CMS, 2019-2025
11 companies · $3,640 in 2025
The $3,640 reported for 2025 was more than what 88% of Neuro-Ophthalmology providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2021: $125 · 2022: $49.73 · 2023: $2,481 · 2024: $4,321 · 2025: $3,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,667 · Consulting Fee: $4,150 · Food and Beverage: $1,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,666.67 |
| Consulting Fee | $4,150.00 |
| Food and Beverage | $1,625.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $4,666.67 | 2023-2024 | Stellaris, Victus, Amvisc |
| Ucb, INC. | $3,078.94 | 2023-2025 | Zilbrysq |
| Argenx US, INC. | $1,200.00 | 2023 | Vyvgart |
| Alexion Pharmaceuticals, INC. | $805.77 | 2024-2025 | Ultomiris |
| Biotissue Holdings INC. | $345.74 | 2024 | |
| Alcon Vision LLC | $225.12 | 2024-2025 | Rhopressa, Rocklatan, Hydrus Microstent |
| Eyepoint US, INC. | $125.00 | 2021 | |
| Apellis Pharmaceuticals, INC. | $120.13 | 2025 | Syfovre |
| Genentech USA, INC. | $109.77 | 2019 | |
| Genentech, INC. | $101.60 | 2019 | |
| Horizon Therapeutics Plc | $49.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yin Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.